ABSTRACT: Electronic health records (EHRs) offer great promises in advancing clinical research and transforming learning health systems. However, complex, temporal EHRs are fraught with biases and present daunting analytical challenges that, if not addressed, can exacerbate health inequities. EHRs data, recorded at irregular time intervals with varying frequencies, are multi-modal and multi-scale including structured data […]
Medicine
Calendar of Events
S
Sun
|
M
Mon
|
T
Tue
|
W
Wed
|
T
Thu
|
F
Fri
|
S
Sat
|
---|---|---|---|---|---|---|
0 events,
|
0 events,
|
0 events,
|
1 event,
-
|
1 event,
-
"The Future of Brain Interfacing" Brain interfacing holds immense promise, both for restoring lost sensory, motor or cognitive function and for the treatment of neurological and neuropsychiatric disorders. The promise is driving a great deal of interest in brain interfacing technologies -- from researchers, industry, investors, and the public -- yet the clinical impact of […] |
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
1 event,
-
Spring 2023 Hybrid-Seminar Series Mondays 1.00-2.00 pm (EST) Towne 225 / Raisler Lounge “For Zoom link, please contact <manu@seas.upenn.edu>” |
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
1 event,
-
The Department of Bioengineering at the University of Pennsylvania and Dr. Pablo Camara are pleased to announce the Doctoral Dissertation Defense of Rachael Aubin. Title: UNDERSTANDING THE CELLULAR AND GENE-REGULATORY MECHANISMS UNDERLYING THE MESENCHYMAL TRANSITION OF EPENDYMOMA TUMOR CELLS USING OMICS DATA Date: Wednesday, March 29 Time: 9:30am Location: Reunion Auditorium, John Morgan Building Zoom link: https://upenn.zoom.us/j/97229075338 The public […] |
1 event,
-
This seminar will be held in person only; snacks will be provided. Immunomodulatory therapies have advanced to clinical trials over the past decade for the treatment of a range of diseases and disorders, from cancer to diabetes to transplant rejection. However, the efficacy of these therapies remains limited, as challenges associated with off-target drug toxicity, […] |
0 events,
|
0 events,
|